N-(2-Chlorobutyl)-4-methylbenzenesulfonamide7a
N-(2-Cyano-1-phenylethyl)-4-methylbenzenesulfonamide4 (2f).
(3d¢). IR
1
1
IR (KBr, cm-1) 3280, 2250, 1590; H NMR (400 Hz, CDCl3) d
(neat, cm-1) 3270, 2850, 1610; H NMR (400 Hz, CDCl3) d 0.76
(t, J = 7.2 Hz, 3H), 1.10–1.50 (m, 6H), 2.42 (s, 3H), 3.33 (m, 3H),
5.10 (br, 1H), 7.30 (d, J = 8.2 Hz, 2H), 7.81 (d, J = 8.2 Hz, 2H);
Anal. Found: C, 54.02; H 6.65; N 5.12. Calc. for C12H16ClNO2S:
C, 53.87; H 6.96; N 4.83%.
2.43 (s, 3H), 2.87 (dd, J = 7.6, 17.2 Hz, 1H), 2.93 (dd, J = 6.0,
17.2 Hz, 1H), 4.57 (m, 1H), 5.40 (br, 1H), 7.10 (d, J = 8.0 Hz,
2H), 7.28 (m, 5H), 7.65 (d, J = 8.4 Hz, 2H); 13C NMR (100 MHz,
CDCl3) d 21.1, 26.3, 54.1, 116.6, 126.0, 127.2, 128.6, 128.9, 129.7,
136.2, 136.9, 143.5; Anal. Found: C, 64.22; H 5.45; N 9.48. Calc.
for C16H16N2O2S: C, 63.98; H 5.37; N 9.33%.
N-(2-Azido-1-benzylethyl)-4-methylbenzenesulfonamide6 (3e).
1
IR (neat, cm-1) 3270, 2090, 1600; H NMR (400 Hz, CDCl3) d
2.42 (s, 3H), 2.72 (dd, J = 7.0, 11.2 Hz, 2H), 3.32 (dd, J = 4.4,
12.4 Hz, 1H), 3.54 (m, 1H), 5.00 (br, 1H), 6.98 (d, J = 8.0 Hz,
2H), 7.20 (m, 5H), 7.58 (d, J = 8.4 Hz, 2H); 13C NMR (100 MHz,
CDCl3) d 21.4, 38.8, 53.7, 54.4, 126.8, 127.2, 128.4, 128.6, 129.0,
129.5, 136.0, 136.7, 143.3.
N-(2-Cyano-2-ethylbutyl)-4-methylbenzenesulfonamide
(2h).
Obtained as a colorless viscous oil after preparative TLC (Rf =
0.26 in Hex/AcOEt = 1/1); IR (neat, cm-1) 3270, 2250, 1600;
1H NMR (400 Hz, CDCl3) d 0.72 (t, J = 7.2 Hz, 3H), 1.04 (t,
J = 6.8 Hz, 3H), 1.47 (m, 2H), 1.59 (m, 2H), 2.43 (s, 3H), 2.75
(td, J = 4.8, 6.0 Hz, 1H), 3.21 (td, J = 4.8, 5.2 Hz, 1H), 4.65
N-(2-Azido-1-phenylethyl)-4-methylbenzenesulfonamide4 (3f).
(br, 1H), 7.32 (d, J = 7.2 Hz, 2H), 7.75 (d, J = 7.2 Hz, 2H); 13
C
1
IR (KBr, cm-1) 3280, 2100, 1590; H NMR (400 Hz, CDCl3) d
NMR (100 MHz, CDCl3) d 9.9, 12.1, 21.6, 23.0, 23.8, 40.9, 55.8,
119.6, 126.9, 129.8, 137.4, 143.8; Anal. Found: C, 60.08; H 7.08;
N 10.06. Calc. for C14H20N2O2S: C, 59.97; H 7.19; N 9.99%.
2.37 (s, 3H), 3.56 (d, J = 6.0 Hz, 1H), 4.45 (m, 1H), 5.40 (br, 1H),
7.10 (d, J = 8.0 Hz, 2H), 7.20 (m, 5H), 7.61 (d, J = 8.4 Hz, 2H).
N-(2-Azido-2-phenylethyl)-4-methylbenzenesulfonamide4 (4f).
N-(2-Azidocyclohexyl)-4-methylbenzenesulfonamide4 (3a). IR
(KBr, cm-1) 3300, 2940, 2090, 1600; 1H NMR (400 Hz, CDCl3) d
1.20–1.30 (m, 4H), 1.60–1.70 (m, 2H), 2.02 (m, 2H), 2.43 (s, 3H),
2.93 (m, 1H), 3.09 (m, 1H), 5.09 (m, 1H), 7.31 (d, J = 8.4 Hz, 2H),
7.80 (d, J = 8.4 Hz, 2H); 13C NMR (100 MHz, CDCl3) d 21.5,
23.6, 23.8, 30.2, 32.4, 59.0, 63.5, 127.0, 129.5, 137.5, 143.2.
1
IR (KBr, cm-1) 3280, 2100, 1590; H NMR (400 Hz, CDCl3) d
2.43 (s, 3H), 3.07 (ddd, J = 4.4, 4.8, 9.2 Hz, 1H), 3.20 (ddd, J =
2.8, 4.4, 9.2 Hz, 1H), 4.59 (dd, J = 5.6, 8.8 Hz, 1H), 4.95 (br, 1H),
7.15 (d, J = 8.0 Hz, 2H), 7.20 (m, 5H), 7.73 (d, J = 8.4 Hz, 2H).
N -(2-Azido-1,2-diphenylethyl)-4-methylbenzenesulfonamide14
(3g). IR (KBr, cm-1) 3270, 2960, 2100, 1600; 1H NMR (400 Hz,
CDCl3) d 2.40 (s, 3H), 4.61 (t, J = 6.8 Hz, 1H), 4.80 (d, J = 6.0 Hz,
1H), 5.69 (d, J = 6.8 Hz, 1H), 7.02 (d, J = 7.6 Hz, 2H), 7.09 (d,
J = 8.0 Hz, 2H), 7.19 (m, 5H), 7.32 (d, J = 8.0 Hz, 2H), 7.49 (d,
J = 7.6 Hz, 2H); 13C NMR (100 MHz, CDCl3) d 21.4, 62.3, 70.1,
126.8, 127.3, 127.4, 127.7, 128.0,128.4, 129.1, 135.4, 136.9, 137.0,
142.9; HRMS: for C21H20NO2S (M - N3)+ calcd 350.1215, found
350.1212.
N-(2-Chlorocyclohexyl)-4-methylbenzenesulfonamide4
(3a¢).
IR (KBr, cm-1) 3270, 2860, 1920, 1600; 1H NMR (400 Hz, CDCl3)
d 1.28 (m, 3H), 1.62 (m, 3H), 1.84 (m, 1H), 2.04 (m, 1H), 2.41
(s, 3H), 3.15 (m, 1H), 3.66 (m, 1H), 4.85 (br, 1H), 7.32 (d, J =
8.0 Hz, 2H), 7.78 (d, J = 8.0 Hz, 2H); Anal. Found: C, 54.04; H
6.11; N 5.00. Calc. for C13H18ClNO2S: C, 54.25; H 6.30; N 4.87%.
N-(2-Azidocyclopentyl)-4-methylbenzenesulfonamide4
(3b).
IR (KBr, cm-1) 3260, 2960, 2100, 1600; 1H NMR (400 Hz, CDCl3)
d 1.40 (m, 1H), 1.62 (m, 3H), 1.92 (m, 2H), 2.43 (s, 3H), 3.38
(dt, J = 5.2, 5.6 Hz, 1H), 3.71 (m, 1H), 5.45 (m, 1H), 7.32 (d, J
= 8.0 Hz, 2H), 7.80 (d, J = 8.0 Hz, 2H);13C NMR (100 MHz,
CDCl3) d 20.8, 21.5, 26.9, 29.0, 30.8, 59.7, 66.9, 126.7, 129.6,
137.0, 143.5.
N-(2-Azido-2-ethylbutyl)-4-methylbenzenesulfonamide
(3h).
Obtained as a white solid after preparative TLC (Rf = 0.67 in
◦
Hex/AcOEt = 1/1); mp 78–79 C; IR (KBr, cm-1) 3240, 2090,
1600; 1H NMR (400 Hz, CDCl3) d 0.73 (t J = 7.6 Hz, 3H), 0.92 (t
J = 7.4 Hz, 3H), 1.30(m, 2H), 1.53 (m, 2H), 2.43 (s, 3H), 3.17–3.27
(m, 2H), 4.83 (d, J = 8.8 Hz, 1H), 7.30 (d, J = 8.0 Hz, 2H), 7.77
(d, J = 8.0 Hz, 2H); 13C NMR (100 MHz, CDCl3) d 10.2, 11.0,
21.5, 21.8, 24.4, 58.1, 67.8, 126.9, 129.3, 137.9, 143.4; HRMS: for
C13H20NO2S (M - N3)+ calcd 254.1215, found 254.1220.
N-(2-Chlorocyclopentyl)-4-methylbenzenesulfonamide4
(3b¢).
IR (KBr, cm-1) 3260, 2890, 1600; H NMR (400 Hz, CDCl3) d
1.41 (m, 1H), 1.60 (m, 3H), 1.92 (m, 2H), 2.41 (s, 3H), 3.55 (m,
1H), 4.10 (m, 1H), 4.80 (m, 1H), 7.33 (d, J = 8.0 Hz, 2H), 7.81 (d,
J = 8.0 Hz, 2H); Anal. Found: C, 52.80; H 6.05; N 5.12. Calc. for
C12H16ClNO2S: C, 52.64; H 5.89; N 5.12%.
1
References
1 (a) J. B. Sweeny, Chem. Soc. Rev., 2002, 31, 247; (b) A. Padwa, W. H.
Pearson, B. N. Lian, S. C. Bergmeier, in Comprehensive Heterocyclic
Chemistry II, ed. A. R. Katritzky, C. W. Rees and E. F. V. Scriven,
Pergamon, New York, 1996, vol. 1a; (c) D. Tanner, Angew. Chem.,
Int. Ed. Engl., 1994, 33, 599; (d) A. Padwa, A. D. Woolhouse, in
Comprehensive Heterocyclic Chemistry, ed. W. Lwowski, Pergamon,
Oxford, 1984, vol. 7.
2 For recent reviews, see: (a) X. E. Hu, Tetrahedron, 2004, 60, 2701;
(b) I. D. G. Watson, L. Yu and A. K. Yudin, Acc. Chem. Res., 2006, 39,
194; (c) Aziridines and Epoxides in Organic Synthesis, ed. A. K. Yudin,
Wiley-VCH, Weinheim, 2006; (d) G. S. Singh, M. D’hooghe and N. D.
Kimpe, Chem. Rev., 2007, 107, 2080.
3 (a) S. Matsubara, T. Kodama and K. Utimoto, Tetrahedron Lett., 1990,
31, 6379; (b) H. M. I. Osborn and J. B. Sweeney, Synlett, 1994, 145;
(c) W.-H. Leung, M. T. Yu, M. C. Wu and L.-L. Yeung, Tetrahedron
Lett., 1996, 37, 891; (d) D. Ferraris, W. J. Drury, III, C. Cox and J.
Lectka, J. Org. Chem., 1998, 63, 4568; (e) Z. Li, M. Fernandez and E. N.
N-(2-Azidooctyl)-4-methylbenzenesulfonamide4
(3c). IR
(neat, cm-1) 3280, 2940, 2100, 1600; 1H NMR (400 Hz, CDCl3) d
0.85 (t, J = 7.2 Hz, 3H), 1.10–1.55 (m, 10H), 2.43 (s, 3H), 3.30 (m,
3H), 4.86 (m, 1H), 7.30 (d, J = 8.0 Hz, 2H), 7.76 (d, J = 8.0 Hz,
2H); 13C NMR (100 MHz, CDCl3) d 14.0, 21.6, 22.5, 25.4, 28.8,
31.6, 32.6, 53.2, 55.0, 127.0, 129.6, 137.0, 143.5.
N-(2-Azidobutyl)-4-methylbenzenesulfonamide4
(3d). IR
(neat, cm-1) 3280, 2100, 1600; H NMR (400 Hz, CDCl3) d 0.74
(t, J = 7.0 Hz, 3H), 1.14–1.55 (m, 6H), 2.42 (s, 3H), 3.28 (m, 3H),
5.00 (m, 1H), 7.30 (d, J = 8.2 Hz, 2H), 7.76 (d, J = 8.2 Hz, 2H);
13C NMR (100 MHz, CDCl3) d 13.7, 21.5, 22.1, 27.5, 32.2, 53.2,
54.8, 126.9, 129.6, 137.6, 143.4.
1
This journal is
The Royal Society of Chemistry 2009
Org. Biomol. Chem., 2009, 7, 3792–3796 | 3795
©